1. Home
  2. NVCR vs CRTO Comparison

NVCR vs CRTO Comparison

Compare NVCR & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CRTO
  • Stock Information
  • Founded
  • NVCR 2000
  • CRTO 2005
  • Country
  • NVCR Jersey
  • CRTO France
  • Employees
  • NVCR N/A
  • CRTO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CRTO Advertising
  • Sector
  • NVCR Health Care
  • CRTO Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • CRTO Nasdaq
  • Market Cap
  • NVCR 1.8B
  • CRTO 2.3B
  • IPO Year
  • NVCR 2015
  • CRTO 2013
  • Fundamental
  • Price
  • NVCR $17.49
  • CRTO $34.21
  • Analyst Decision
  • NVCR Buy
  • CRTO Buy
  • Analyst Count
  • NVCR 5
  • CRTO 10
  • Target Price
  • NVCR $26.60
  • CRTO $53.78
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • CRTO 251.2K
  • Earning Date
  • NVCR 10-30-2024
  • CRTO 10-30-2024
  • Dividend Yield
  • NVCR N/A
  • CRTO N/A
  • EPS Growth
  • NVCR N/A
  • CRTO 1230.66
  • EPS
  • NVCR N/A
  • CRTO 1.65
  • Revenue
  • NVCR $549,964,000.00
  • CRTO $1,956,857,000.00
  • Revenue This Year
  • NVCR $16.23
  • CRTO N/A
  • Revenue Next Year
  • NVCR $6.09
  • CRTO $6.88
  • P/E Ratio
  • NVCR N/A
  • CRTO $24.81
  • Revenue Growth
  • NVCR 8.33
  • CRTO 1.64
  • 52 Week Low
  • NVCR $10.87
  • CRTO $22.10
  • 52 Week High
  • NVCR $24.74
  • CRTO $49.93
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • CRTO 56.27
  • Support Level
  • NVCR $15.61
  • CRTO $40.63
  • Resistance Level
  • NVCR $17.31
  • CRTO $43.76
  • Average True Range (ATR)
  • NVCR 1.29
  • CRTO 1.12
  • MACD
  • NVCR 0.05
  • CRTO 0.23
  • Stochastic Oscillator
  • NVCR 11.59
  • CRTO 74.54

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CRTO Criteo S.A.

Headquartered in Paris, Criteo is one of the leading ad-tech companies in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.

Share on Social Networks: